Navigation Links
Using Drugs as Weapons can Never Be 'non Lethal', Say Doctors

In a report [Thursday, 24 May 2007] the BMA says it is extremely concerned at the growing interest of world governments in using drugs in law enforcement situations, in the belief that these can be non lethal.

The use of drugs as weapons1, produced by the BMAs Board of Science, concludes that it is impossible to deliver the right drug in the right dose to the right individuals in a way that is both effective and does not cause significant deaths. The report highlights the Moscow theatre siege of October 2002 the Russian authorities said a derivative of the drug fentanyl2 was delivered through the air-conditioning system to end the siege. This killed over 130 hostages.

Dr Vivienne Nathanson, BMA Head of Science and Ethics, said: It is important to remember that target groups are likely to comprise people of varying weights, sizes and ages; some may be pregnant or have pre-existing medical conditions. It is virtually impossible to control the amount of a drug delivered or to ensure it acts without producing toxic effects or causing death.

It is disingenuous of governments to describe drugs as non-lethal there is no difference between a drug and a poison except the dose. Using drugs as a method of law enforcement may constitute a violation of international conventions which prohibit the use of chemical weapons. This is of great concern to the BMA.

The BMA is keen to alert doctors to the fact that medical knowledge may be called upon for the development of drugs as weapons, as well as antidotes and treatments. Future advances in drug development may spawn more sophisticated and sinister agents that may not be limited to science fiction.

Key recommendations from the report state that organizations that represent healthcare professionals should:

Advocate a multidisciplinary input to policy-making about all weapons and their use in relation to international law or arms control and disar mament, international humanitarian law and human rights law.

Ensure that governments and policy-makers in military and law enforcement agencies who may be considering the use of drugs as weapons understand the fundamental scientific, legal and ethical considerations surrounding such use.

Work to promote the norms prohibiting the use of poisons, and therefore the Biological and Toxin Weapons Convention [BTWC] and the Chemical Weapons Convention [CWC]. They should further promote understanding that the use of drugs as weapons would violate such norms.

Advocate that, in the event of those states which are party to the CWC deciding that drugs can be used for law enforcement; these states declare the types and quantities of such agents.

Ensure that the consequences of the use of drugs as weapons for military purposes are considered as part of the review of such weapons required by international humanitarian law.

Advocate against the use of drugs as weapons and not be involved in the training of military or law enforcement personnel in the administration of drugs as weapons.

Recognise the complex ethical dilemmas raised by research on, development of, planning for and use of drugs as weapons and promote professional debate on these matters.

Develop guidelines for any healthcare professional involved in research and the development of agents, materials or knowledge that might be put to a dual use.

Ensure that the pharmaceutical industry is alert to the possibility that their research and products might be put to malign use, and work with them to prevent this.

Encourage their members to abide by professional codes that prohibit involvement in development of dual use technologies or materials.


'"/>




Related medicine news :

1. Preventing Strokes Using Less Invasive Techniques
2. Using Cholesterol Lowering Drugs Effectively
3. Using herbal remedies with chemotherapy may not be a good idea
4. Teenagers Using Hormones And Dietary Supplements To Good Physique
5. Using Stem Cells To Treat Incontinence In Women
6. Using Eyes As The Line Of Reference For Fetal Brain Imaging
7. Remote Robotic Surgery Using Miniature Robots
8. Driving While Using A Mobile Phone May Be Dangerous
9. Detecting Brain Abnormalities in Babies Using New Brain Scanners.
10. Mobilizing Stem Cells at the Injured Site Using Hyperbaric Oxygen Treatments.
11. Treatment of Sickle Cell Anemia Using Gene Therapy.
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/23/2017)... Boulder, CO (PRWEB) , ... February 23, 2017 , ... ... to announce the winner of the 2016 National Education Policy Center Bunkum Award. We ... report reviewed in 2016. , This year’s Bunkum winner is the Center for American ...
(Date:2/23/2017)... ... February 23, 2017 , ... The American Cleft Palate-Craniofacial Association (ACPA) is pleased ... KLS is a longtime supporter of the event. , "We are pleased that KLS ... Dr. Bob Havlik, 2017 ACPA President. "KLS Martin has a long track record of ...
(Date:2/23/2017)... ... February 23, 2017 , ... Rosica Communications, a ... content marketing, social media management, corporate communications, SEO and cause marketing, is opening ... in nearby New Hampshire, Massachusetts and Canada, Rosica will focus on expanding its ...
(Date:2/23/2017)... ... February 23, 2017 , ... Dr. David Mahon leads Siena Dental, ... Dr. Mahon was named a 2017 Top Patient Rated Henderson Dentist by ... directory that recognizes local physicians and dentists who have earned high ratings and superior ...
(Date:2/23/2017)... Phoenix (PRWEB) , ... February 23, 2017 , ... ... in Phoenix, announced today that it will soon begin franchising throughout the U.S. ... the mission to help bring the practice of meditation mainstream. Current Meditation will ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017 Report analyzes the worldwide markets for ... analytics for the US, Canada , ... Asia-Pacific , Latin America , ... for the period 2015 through 2022. Also, a six-year historic ... are derived from primary and secondary research. Company profiles are ...
(Date:2/24/2017)... YORK , Feb. 23, 2017  This report ... Thousand by the following Products: Intermediates, ... in the report include Pharmaceuticals, and Agrochemicals. The report ... Japan , Europe , and ... for the period 2015 through 2022. Also, a six-year ...
(Date:2/24/2017)... , Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., ... announced that it has acquired exclusive worldwide rights ... best-in-class innovative HDAC inhibitor targeting hematological and solid ... 14 Phase 1 and 2 clinical trials of ... have already been completed, demonstrating that ...
Breaking Medicine Technology: